Recent Summits in Berlin and Princeton Were Highly Successful in Helping Manufacturers, CMOs, CPOs & 3PLs Forge Partnerships for Cost-Effective Compliance with Upcoming Serialization Deadlines
Princeton, NJ – Supply Chain Wizard – a leading full-service global consulting firm specializing in serialization and traceability, as well as supply chain strategy and operational transformation programs – and Medicines for Europe, an organization serving as the voice of Europe’s generic, biosimilar and value-added medicines industries, will co-host a Pharma CMO Summit on June 14, 2017 at the Epic Sana Hotel in Lisbon, Portugal. The event is co-located with Medicine for Europe's Annual Conference, which attracts over 300 pharma executives in the generic & biosimilar industries, offering opportunities for synergies among senior-level decision influencers.
The gathering offers a unique opportunity for pharmaceutical industry partners to make or finalize strategies for both initial compliance and optimized post-implementation operations. The Pharma CMO Summit will bring together manufacturers, CMOs, CPOs, 3PLs and solution providers for education and interactive activities centered on serialization compliance, serialized operations and value beyond compliance. The Lisbon event is the latest in a series of such summits initiated by Supply Chain Wizard, most recently in Princeton, NJ.
Top-line results from the Princeton Summit offer a snapshot of industry-wide serialization progress. With more than 125 senior-level attendees comprising track & trace solutions experts, pharma manufacturers, packagers and logistics providers, the two-day event featured speakers on a variety of pertinent topics, as well as a series of quick-rotation meetings intended to match needs with expertise.
The Princeton gathering brought together executives representing a broad spectrum of functional areas within their respective organizations. The resulting partnership potential was both welcome and well-received: a 2016 SCW survey of U.S. and EU pharma manufacturers revealed that 65% of CMOs did not have sufficient resources for serialization, and that more than half had not begun their first serialization project.
A main objective of the upcoming Lisbon Summit is providing flexible strategies and solutions for achieving practical paths to compliance. Leading solutions on the market focused on efficient, cost-effective incorporation will be modeled, and case study presentations will help educate trading partners on likely implementation challenges. Finally, interactive activities will showcase the value beyond compliance that production digitization brings to manufacturing operations.
“Like its successful predecessors, the Lisbon Pharma CMO Summit will bring together the full spectrum of supply chain partners,” said Evren Ozkaya, CEO of Supply Chain Wizard. “The result yields opportunities for partnerships, collaborations and improved business practices above and beyond the need to meet pending regulatory requirements.”
